Vaccinations
Vaccinations datasets in the CDC Open Data Catalog
This page contains all datasets in the Vaccinations category of the CDC Open Data Catalog.
Total Datasets in Category: 82 Last Updated: 07/14/2025
Datasets in this Category
COVID-19 Booster Dose Eligibility in the United States
Description: This site provides historical data related to COVID-19 booster dose eligibility presented on two CDC COVID Data Tracker sites: Vaccinations in the US and Vaccination Equity. Data are updated weekly on Thursdays. Some COVID-19 vaccine recipients are eligible to receive booster doses, and criteria for booster eligibility may change over time. Data and footnotes will be updated to align with the current recommendations. CDC counts people as having “received a booster dose” if they are fully vaccinated and received another dose of any COVID-19 vaccine on or after August 13, 2021. This does not distinguish whether the recipient is immunocompromised and received an additional dose Data Limitations: The booster eligibility metric excludes fully vaccinated recipients who have an “Other” primary series vaccine type. Booster eligibility counts and percentages exclude vaccine administrations reported by Texas as the primary series cannot be linked to booster dose in the aggregate data submitted by Texas. Footnotes: CDC counts people as being “eligible to get a booster dose<
Schema: dwv_vacc_data
Table Name: covid19_booster_dose_eligibility_us__jk8p_fqhn
Dataset ID: jk8p-fqhn
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, demographics
COVID-19 Primary Series Completion, Booster Dose Eligibility, and Booster Dose Receipt by Age, United States
Description: This site provides historical data beginning June 22, 2022, for the visualization presented on COVID-19 Data Tracker’s “Vaccinations in the United States” site titled “Primary Series Completion, Booster Dose Eligibility, and Booster Dose Receipt by Age, United States”. Fully Vaccinated / Completed Primary Series: For surveillance purposes, COVID Data Tracker counts people as being "fully vaccinated" or as having "completed a primary series" if they received two doses on different days (regardless of time interval) of the two-dose mRNA series or received one dose of a single-dose vaccine. When the vaccine manufacturer is not reported, the recipient is considered fully vaccinated with two doses. First Booster Dose: For surveillance purposes, the count and percentage of people who received a first booster dose includes anyone who is fully vaccinated and has received another dose of COVID-19 vaccine since August 13, 2021. This includes people who received a first booster dose and people who received an additional primary series dose as this metric does not distinguish if the recipient is immunocompromised and received an additional dose. First booster dose eligibility: CDC counts people as being " eligible for a first booster dose" if it has been at least 5 months since completion of a Pfizer-BioNTech or Moderna primary series or at least 2 months since receipt of a Janssen (Johnson & Johnson) singe-dose vaccine. Second Booster Dose: For surveillance purposes, the count and percentage of people who received a second booster dose includes anyone who is fully vaccinated and has received two subsequent doses of COVID-19 vaccine since August 13, 2021. This includes people who received two booster doses and people who received one additional dose and one booster dose. The count of people who received a second booster dose and the percentage of people with a first booster who received a second booster dose does not account for whether a person is immunocompromised or time interval since first booster dose. Second booster dose eligibility: CDC counts people as being "eligible for a second booster dose" if it has been at least 4 months since receiving a first booster dose. Limitations to counting people with a second booster dose: Due to the aggregate vaccination record reporting method used by Idaho for its residents under the age of 18 years and by Texas for all its residents, CDC counts all 4th doses received by these populations as a second booster dose. This includes immunocompromised individuals who received a three-dose primary series and only one booster dose. This limitation may lead to an undercount of people who received the single-dose J&J/Janssen vaccine as their primary series and two booster doses. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_primary_booster_eligibility_age__3pbe_qh9z
Dataset ID: 3pbe-qh9z
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, demographics
COVID-19 Vaccinations in the United States,County
Description: Overall US COVID-19 Vaccine administration and vaccine equity data at county level. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccinations_us_county__8xkx_amqh
Dataset ID: 8xkx-amqh
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, immunization
COVID-19 Vaccinations in the United States,Jurisdiction
Description: Overall US COVID-19 Vaccine deliveries and administration data at national and jurisdiction level. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccinations_us_jurisdiction__unsk_b7fc
Dataset ID: unsk-b7fc
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, immunization
COVID-19 Vaccination Age and Sex Trends in the United States, National and Jurisdictional
Description: This site provides data for select demographic characteristics (age, sex, and age by sex) of people receiving COVID-19 vaccinations in the United States at the national and jurisdictional levels. For national race/ethnicity data, please visit COVID-19 Vaccination Demographics in the United States,National. For jurisdictional race/ethnicity data, please visit the relevant health department website if available. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccination_age_sex_trends_us_r__5i5k_6cmh
Dataset ID: 5i5k-6cmh
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, demographics
Archive: COVID-19 Vaccination and Case Trends by Age Group, United States
Description: After October 13, 2022, this dataset will no longer be updated as the related CDC COVID Data Tracker site was retired on October 13, 2022. This dataset contains historical trends in vaccinations and cases by age group, at the US national level. Data is stratified by at least one dose and fully vaccinated. Data also represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccination_case_trends_age_us___gxj9_t96f
Dataset ID: gxj9-t96f
Category: Vaccinations
Tags: administration, cases, coronavirus, covid-19, immunization
Archive: COVID-19 Vaccination Demographic Trends by Report Date, National
Description: This data dictionary provides information about archived demographic trend data for people receiving COVID-19 vaccinations in the United States at the national level. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities. These data have been archived to provide historical demographic trend data for COVID-19 vaccine recipients prior to CDC converting the Vaccination Demographic Trends site to using data based on the date of vaccine administration. Previously, the Vaccination Demographic Trends site presented trend data by the date the vaccination was reported to CDC.
Schema: dwv_vacc_data
Table Name: covid19_vaccination_demographics_trends__2vpi_n544
Dataset ID: 2vpi-n544
Category: Vaccinations
Tags: administration, coronavirus, covid-19, immunization, izdl
COVID-19 Vaccination Demographics in the United States,National
Description: Overall Demographic Characteristics of People Receiving COVID-19 Vaccinations in the United States at national level. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccination_demographics_us_nat__km4m_vcsb
Dataset ID: km4m-vcsb
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, demographics
COVID-19 Vaccination Trends in the United States,National and Jurisdictional
Description: Overall Trends in Number of COVID-19 Vaccinations in the US at national and jurisdictional levels. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccination_trends_us_national___rh2h_3yt2
Dataset ID: rh2h-3yt2
Category: Vaccinations
Tags: administration, coronavirus, covid-19, immunization, izdl
COVID-19 Updated Vaccines Distributed
Description: This site provides historical data beginning June 14, 2023, for the visualization presented on COVID-19 Data Tracker’s “Vaccinations in the United States" site titled “US COVID-19 Vaccine Doses Delivered by Vaccine Type” Definition for Distributed: Cumulative number of COVID-19 updated vaccine doses distributed in the United States. CDC is no longer reporting metrics for Johnson & Johnson, and the original Pfizer and Moderna vaccines. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccines_distributed__hwk8_wu83
Dataset ID: hwk8-wu83
Category: Vaccinations
Tags: administration, coronavirus, covid-19, immunization, izdl
COVID-19 Vaccines Up to Date Status
Description: This site provides historical data beginning June 14, 2023, for the visualization presented on COVID-19 Data Tracker’s “Vaccinations in the United States” site titled “Percent of Total Population Who Are Up to Date with COVID-19 Vaccines” Definition for Up to Date: For surveillance purposes people are ‘Upto Date’ with COVID-19 vaccines based on the following criteria: People ages 6 years and older: Are up to date if they received 1 updated Pfizer-BioNTech or Moderna COVID-19 vaccine. Children ages 6 months to 5 years who received the Pfizer-BioNTech COVID-19 vaccine: Are up to date if: At ages 6 months to 4 years, they received 3 COVID-19 vaccine doses, including at least 1 updated COVID-19 dose; at age 5 years, they received at least 1 updated COVID-19 vaccine dose. Children ages 6 months to 5 years who received the Moderna COVID-19 vaccine: Are up to date if they received 2 Moderna COVID-19 vaccine doses, including at least 1 updated COVID-19 vaccine dose. People who are unable or choose not to get a recommended mRNA vaccine: Are up to date if they receive the Novavax COVID-19 vaccine doses approved for their age group. CDC uses US Census estimates for the total populations within each specified demographic group regardless of prior vaccination status as denominators. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Schema: dwv_vacc_data
Table Name: covid19_vaccines_status_xplanation_onve__9b5z_wnve
Dataset ID: 9b5z-wnve
Category: Vaccinations
Tags: administration, age, coronavirus, covid-19, immunization
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna
Description: New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Pfizer Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Initial-Allocations-Pfizer/saz5-9hgg Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh
Schema: dwv_vacc_data
Table Name: covid19_vaccine_distribution_allocation__b7pe_5nws
Dataset ID: b7pe-5nws
Category: Vaccinations
Tags: coronavirus, covid-19, vaccination
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer
Description: New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Moderna Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh
Schema: dwv_vacc_data
Table Name: covid19_vaccine_distribution_allocation__saz5_9hgg
Dataset ID: saz5-9hgg
Category: Vaccinations
Tags: coronavirus, covid-19, vaccination
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Janssen
Description: New weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Pfizer Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Initial-Allocations-Pfizer/saz5-9hgg Moderna Vaccine Data- https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws
Schema: dwv_vacc_data
Table Name: covid19_vaccine_distribution_allocation__w9zu_fywh
Dataset ID: w9zu-fywh
Category: Vaccinations
Tags: coronavirus, covid-19, vaccination
Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine
Description: Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Demographic Characteristics • COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.
Schema: dwv_vacc_data
Table Name: cumulative_adults_vaccinated_covid19_23__hm35_qkiu
Dataset ID: hm35-qkiu
Category: Vaccinations
Tags: adults, covid-19 vaccination, nis-acm
Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.
Description: National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention. Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__6p3a_6xr9
Dataset ID: 6p3a-6xr9
Category: Vaccinations
Tags: adults, age, age group, covid-19, covid-19 vaccination
Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM (Archived)
Description: Cumulative Influenza Vaccination Coverage Age Group, Race/Ethnicity, and Jurisdiction, Adults 18 Years and Older, United States, National Immunization Survey Adult COVID Module. The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__8dyx_9z99
Dataset ID: 8dyx-9z99
Category: Vaccinations
Tags: adults, coverage, flu vaccination, influenza, vaccination
Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, US, National Immunization Survey-Adult COVID Module
Description: Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, United States, Data Source: National Immunization Survey-Adult COVID Module. • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__b6uq_hdgz
Dataset ID: b6uq-hdgz
Category: Vaccinations
Tags: adults, coverage, flu vaccination, influenza, vaccination
Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Persons 18-49 years
Description: Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Persons 18-49 years • These monthly flu vaccination coverage estimates for pregnant persons are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC’s Immunization Safety Office and nine integrated health care organizations.§ This system has been used annually to estimate vaccination coverage among pregnant persons. COVID-19 vaccination coverage for pregnant persons is available here. • Figure 3A. Monthly Cumulative Influenza Vaccination Coverage*, by Flu Season and Race/Ethnicity, Pregnant Persons 18-49 years, United States, Data Source: Vaccine Safety Datalink • Figure 3B. Cumulative Influenza Vaccination Coverage*, by Month, Flu Season, and Race/Ethnicity, Pregnant Persons 18-49 years, United States, Data Source: Vaccine Safety Datalink • For any month’s coverage estimate, the denominator is the number of persons with a pregnancy during the current flu season (defined as August through March) beginning before or during the specified month. The numerator is the subset of the denominator who have received flu vaccination prior to, during, or after pregnancy. The denominator increases as more persons are identified as pregnant or having been pregnant during the flu season. Cumulative vaccination coverage for one month may be lower than cumulative coverage for a previous month due to addition to the denominator of persons who are less likely to have received vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__fz77_au2z
Dataset ID: fz77-au2z
Category: Vaccinations
Tags: children, flu, influenza, nis, nis-flu
Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years
Description: Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years • These monthly flu vaccination coverage estimates for pregnant women are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC’s Immunization Safety Office and nine integrated health care organizations.§ This system has been used annually to estimate vaccination coverage among pregnant women. COVID-19 vaccination coverage for pregnant women is available here. • Figure 3A. Monthly Cumulative Influenza Vaccination Coverage*, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years, United States, Data Source: Vaccine Safety Datalink • Figure 3B. Cumulative Influenza Vaccination Coverage*, by Month, Flu Season, and Race/Ethnicity, Pregnant Women 18-49 years, United States, Data Source: Vaccine Safety Datalink • For any month’s coverage estimate, the denominator is the number of women with a pregnancy during the current flu season (defined as August through March) beginning before or during the specified month. The numerator is the subset of the denominator who have received flu vaccination prior to, during, or after pregnancy. The denominator increases as more women are identified as pregnant or having been pregnant during the flu season. Cumulative vaccination coverage for one month may be lower than cumulative coverage for a previous month due to addition to the denominator of women who are less likely to have received vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__nkr7_scx6
Dataset ID: nkr7-scx6
Category: Vaccinations
Tags: children, flu, influenza, nis, nis-flu
Cumulative Influenza Vaccination Coverage by Age Group, Race/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older - NIS ACM
Description: Cumulative Influenza Vaccination Coverage by Age Group, Race/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older, United States, National Immunization Survey-Adult COVID Module. Archived data are available at the following locations: 1. https://data.cdc.gov/resource/8dyx-9z99 2. https://data.cdc.gov/resource/3myw-4j4q • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__ty79_wym3
Dataset ID: ty79-wym3
Category: Vaccinations
Tags: adults, coverage, flu vaccination, influenza, vaccination
Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics, Adults 18 Year and Older, NIS Adult COVID Module
Description: Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics, Adults 18 Year and Older, NIS Adult COVID Module • The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vaccination_covera__v22g_tzpk
Dataset ID: v22g-tzpk
Category: Vaccinations
Tags: adults, ethnicity, flu, flu vaccination, race
Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States
Description: Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States Vaccinations • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView: https://www.cdc.gov/flu/fluvaxview/index.htm.
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vacc_coverage_diff__2den_c3u2
Dataset ID: 2den-c3u2
Category: Vaccinations
Tags: influenza, flu, nis, children, vaccine coverage, flu shot
Source Data: https://data.cdc.gov/d/2den-c3u2
Cumulative Influenza Vaccination Coverage, Adults 18 years and older, by Age Group and Race/Ethnicity, United States
Description: Cumulative Influenza Vaccination Coverage, Adults 18 years and older, by Age Group and Race/Ethnicity, United States, 2020-21, IPSOS Knowledge Panel Omnibus and NORC AmeriSpeak Omnibus Surveys
Schema: dwv_vacc_data
Table Name: cumulative_influenza_vacc_covrg_adults___kmap_fsfn
Dataset ID: kmap-fsfn
Category: Vaccinations
Tags: adults, age group, ethnicity, flu, flu vaccination
Cumulative Percentage of Adults 60 Years and Older Vaccinated with RSV Vaccine by Demographic Characteristics
Description: Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Demographic Characteristics • RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: cumulative_percent_adults60_rsv_vaccine__mx2d_yjrk
Dataset ID: mx2d-yjrk
Category: Vaccinations
Tags: nis-acm, older adults, rsv, vaccination
DEV_Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States
Description: This asset is to be used for testing purposes only.
Schema: dwv_vacc_data
Table Name: dev_weekly_cumulative_doses_influenza_v__ys29_m7jh
Dataset ID: ys29-m7jh
Category: Vaccinations
Tags: vaccines
Source Data: https://data.cdc.gov/d/ys29-m7jh
Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities
Description: Household Pulse Survey (HPS): HPS is a rapid-response survey of adults ages ≥18 years led by the U.S. Census Bureau, in partnership with seven other federal statistical agencies, to measure household experiences during the COVID-19 pandemic. Detailed information on probability sampling using the U.S. Census Bureau’s Master Address File, questionnaires, response rates, and bias assessment is available on the Census Bureau website (https://www.census.gov/data/experimental-data-products/household-pulse-survey.html). Data from adults age ≥18 years are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). Data are weighted to represent total persons age 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Data from adults age ≥18 years are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). For more information on this survey, see https://www.census.gov/programs-surveys/household-pulse-survey.html. Data are weighted to represent total persons age 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Responses in the Household Pulse Survey (https://www.census.gov/programs-surveys/household-pulse-survey.html) are self-reported. Estimates of vaccination coverage may differ from vaccine administration data reported at COVID-19 Vaccinations in the United States (https://covid.cdc.gov/covid-data-tracker/#vaccinations).
Schema: dwv_vacc_data
Table Name: hps_covid19_vaccine_disabilities__muep_c3qd
Dataset ID: muep-c3qd
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, disability, hps
Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities
Description: Household Pulse Survey (HPS): HPS is a rapid-response survey of adults ages ≥18 years led by the U.S. Census Bureau, in partnership with seven other federal statistical agencies, to measure household experiences during the COVID-19 pandemic. Detailed information on probability sampling using the U.S. Census Bureau’s Master Address File, questionnaires, response rates, and bias assessment is available on the Census Bureau website (https://www.census.gov/data/experimental-data-products/household-pulse-survey.html). Data from adults ages ≥18 years and older are collected by a 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). Data are weighted to represent total persons ages 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Data from adults ages ≥18 years and older are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). For more information on this survey, see https://www.census.gov/programs-surveys/household-pulse-survey.html. Data are weighted to represent total persons ages 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Responses in the Household Pulse Survey (https://www.census.gov/programs-surveys/household-pulse-survey.html) are self-reported. Estimates of vaccination coverage may differ from vaccine administration data reported at COVID-19 Vaccinations in the United States (https://covid.cdc.gov/covid-data-tracker/#vaccinations).
Schema: dwv_vacc_data
Table Name: hps_covid19_vaccine_disabilities__u4vw_xsmf
Dataset ID: u4vw-xsmf
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, disability, hps
Archive: COVID-19 LTC Program Vaccinations and Trends in the United States, Jurisdiction
Description: The Federal Pharmacy Partnership for Long-Term Care (LTC) Program was a partnership between CDC and CVS, Walgreens, and Managed Health Care Associates, Inc. The program offered on-site COVID-19 vaccination services for residents of nursing homes and assisted living facilities. The Federal Pharmacy Partnership for LTC Program was in effect after vaccines became available to April 23, 2021. This is the historical archived data related to the LTC Program and represents data that was shown on COVID Data Tracker through September 30, 2021. Twelve variables that provided data on residents and staff vaccinated through the program were removed from the COVID-19 Vaccinations in the United States,Jurisdiction dataset. LTC was removed as an option from the location variable in the following datasets: COVID-19 Vaccinations in the United States,Jurisdiction and COVID-19 Vaccination Trends in the United States,National and Jurisdictional.
Schema: dwv_vacc_data
Table Name: ltc_covid19_vaccinations_trends_us_juri__egm8_9wq7
Dataset ID: egm8-9wq7
Category: Vaccinations
Tags: administration, coronavirus, covid-19, immunization, izdl
Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses, by Age Group, and Jurisdiction, United States
Description: • Monthly Cumulative Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses, by Age Group and Jurisdiction • COVID-19 vaccination coverage for children and adults is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/).
Schema: dwv_vacc_data
Table Name: monthly_cumulative_covid19_vaccinations__3bmy_cyyd
Dataset ID: 3bmy-cyyd
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, vsd
Source Data: https://data.cdc.gov/d/3bmy-cyyd
Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024-25 and 2023-24 Seasons, by Age Group and Jurisdiction, United States
Description: • Monthly Cumulative Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024─25 and 2023─24 Seasons, by Age Group and Jurisdiction, by Age Group and Jurisdiction • COVID-19 vaccination coverage for children and adults is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/)
Schema: dwv_vacc_data
Table Name: monthly_cumulative_covid19_vaccinations__q84f_e68r
Dataset ID: q84f-e68r
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, vsd
Source Data: https://data.cdc.gov/d/q84f-e68r
Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States
Description: Monthly Cumulative Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction • Estimated Number of COVID-19 vaccinations among children 6 months–17 years and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19. (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html)
Schema: dwv_vacc_data
Table Name: monthly_cumulative_covid19_vaccinations__vugp_mqip
Dataset ID: vugp-mqip
Category: Vaccinations
Tags: covid-19 vaccination, iis, immunization information system
Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States
Description: Monthly Cumulative Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction • Estimated Number of COVID-19 vaccinations among children 6 months–17 years and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19. (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html)
Schema: dwv_vacc_data
Table Name: monthly_cumulative_covid19_vaccinations__wtw5_4wi3
Dataset ID: wtw5-4wi3
Category: Vaccinations
Tags: covid-19 vaccination, iis, immunization information system
Monthly Cumulative Number and Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States
Description: Monthly Cumulative Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States. Nirsevimab coverage for children 0 to 7 months is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/).
Schema: dwv_vacc_data
Table Name: monthly_cumulative_nirsevimab_children___4bdk_kyzv
Dataset ID: 4bdk-kyzv
Category: Vaccinations
Tags: iis, iqvia, nis-acm, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/4bdk-kyzv
Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States
Description: Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction • Estimated nirsevimab coverage for children 0-19 months is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: monthly_cumulative_nirsevimab_children___ku7p_zn4c
Dataset ID: ku7p-zn4c
Category: Vaccinations
Tags: iis, immunization information system, rsv vaccination
Monthly Cumulative Number and Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States
Description: • Monthly Cumulative Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States. • Respiratory Syncytial Virus (RSV) vaccination coverage for adults is assessed through U.S. jurisdictions’ Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/).
Schema: dwv_vacc_data
Table Name: monthly_cumulative_rsv_vaccinations_by___n2zz_25mk
Dataset ID: n2zz-25mk
Category: Vaccinations
Tags: iis, iqvia, nis-acm, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/n2zz-25mk
Monthly Cumulative Number and Percent of Adults 60 Years and Older Who Received at least one RSV Vaccination Doses by Jurisdiction, United States
Description: Monthly Cumulative Number and Percent of Adults 60 Years and Older Who Received at least one RSV Vaccination Doses by Jurisdiction • Estimated Respiratory Syncytial Virus (RSV) vaccination coverage for adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: monthly_cumulative_rsv_vaccinations_by___scrf_8d7w
Dataset ID: scrf-8d7w
Category: Vaccinations
Tags: iis, immunization information system, rsv vaccination
National Immunization Survey Adult COVID Module (NIS-ACM): COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)-Archived
Description: National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics.
Schema: dwv_vacc_data
Table Name: national_immunization_survey_adult_covi__udsf_9v7b
Dataset ID: udsf-9v7b
Category: Vaccinations
Tags: covid19, covid-19 vaccination, immunization, nis-acm, vaccination
National Immunization Survey Adult COVID Module (NIS-ACM): COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)
Description: • National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on the Updated 2023-24 COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics. • The data start in October 2023. • The archived data can be found here:
Schema: dwv_vacc_data
Table Name: nis_acm_covidvaxviews_data__uc4z_hbsd
Dataset ID: uc4z-hbsd
Category: Vaccinations
Tags: covid-19, covid-19 vaccination, immunization, nis-acm, vaccination
National Immunization Survey Adult COVID Module (NIS-ACM): RespVaxView| Data | Centers for Disease Control and Prevention (cdc.gov)
Description: • National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on the updated 2024-25 COVID-19 vaccine, the 2024-25 seasonal flu vaccine, and the RSV vaccine uptake and confidence. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics. • The data start in September 2024. • The archived data can be found here: - 2023-24 season: https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/uc4z-hbsd/about_data - Before October 2023: https://data.cdc.gov/Vaccinations/National-Immunization-Survey-Adult-COVID-Module-NI/udsf-9v7b/about_data
Schema: dwv_vacc_data
Table Name: nis_acm_respvaxview_data_cdc_xplanation__si7g_c2bs
Dataset ID: si7g-c2bs
Category: Vaccinations
Tags: covid-19 vaccination, nis-acm, rsv vaccination, vaccination, vaccination coverage, vaccine confidence
Source Data: https://data.cdc.gov/d/si7g-c2bs
National Immunization Survey Adult COVID Module (NIS-ACM): Vaccination Status and Intent by Demographics
Description: National Immunization Survey Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent by demographics. Following collection of August 2021 survey data, an error in data processing led to incorrect categorization of some survey respondents; some respondents who should have been categorized as MSA: Principal City instead were categorized as MSA: Non-Principal City. Data downloaded during the period September 12, 2021 through September 30, 2021 may have incorrect estimates by MSA status, SVI of county of residence, and political leaning of county of residence.
Schema: dwv_vacc_data
Table Name: nis_acm_vaccination_status_intent_demog__iwxc_qftf
Dataset ID: iwxc-qftf
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, nis-acm
National Immunization Survey Adult COVID Module (NIS-ACM): Trends in Behavioral Indicators Among Unvaccinated People
Description: National Immunization Survey-Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. Trends in behavioral indicators represent the percent of unvaccinated people responding to each of the indicators by intent status and by week for the national-level view, and by month for the jurisdiction-level view.
Schema: dwv_vacc_data
Table Name: nis_adult_covid_behavior_indicators_unv__qz99_wyhv
Dataset ID: qz99-wyhv
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, nis-acm
National Immunization Survey Adult COVID Module (NIS-ACM): Trends in Vaccination Status and Intent
Description: National Immunization Survey-Adult COVID Module (NIS-ACM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent by week for the national-level view, and by month for the jurisdiction-level view.
Schema: dwv_vacc_data
Table Name: nis_adult_covid_module_vaccination_tren__akkj_j5ru
Dataset ID: akkj-j5ru
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, nis-acm
National Immunization Survey Child COVID Module (NIS-CCM): COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)-Archived
Description: National Immunization Survey Child COVID Module (NIS-CCM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics.
Schema: dwv_vacc_data
Table Name: nis_ccm_covidvaxviews_cdc_archived__uny6_e3dx
Dataset ID: uny6-e3dx
Category: Vaccinations
Tags: covid-19, covid-19 vaccination, immunization, nis-ccm, vaccination
National Immunization Survey Child COVID Module (NIS-CCM): Vaccination Status and Intent by Demographics | Data | Centers for Disease Control and Prevention (cdc.gov)
Description: National Immunization Survey Child COVID Module (NIS-CCM): CDC is providing information on COVID-19 vaccine confidence to supplement vaccine administration data. These data represent trends in vaccination status and intent, and other behavioral indicators, by demographics and other characteristics.
Schema: dwv_vacc_data
Table Name: nis_ccm_vaccination_status_intent_demog__gr26_95h2
Dataset ID: gr26-95h2
Category: Vaccinations
Tags: covid-19 vaccination, covid tracker, nis-ccm
Vaccination Concerns, Issues, and Motivators | RespVaxView | Data | Centers for Disease Control and Prevention (cdc.gov)
Description: • CDC is providing information on COVID-19, flu, and RSV vaccination concerns, issues, and motivators to supplement weekly vaccination data. These monthly data represent trends in vaccination concerns, issues, and motivators, by demographics and other characteristics. • The data start in August 2024.
Schema: dwv_vacc_data
Table Name: vaccination_concerns_issues_motivators___94wp_9pid
Dataset ID: 94wp-9pid
Category: Vaccinations
Tags: covid-19 vaccination, flu vaccination, rsv vaccination
Source Data: https://data.cdc.gov/d/94wp-9pid
Vaccination Coverage among Adults (18+ Years)
Description: Vaccination Coverage among Adults (18+ Years) • Data on adult vaccination coverage from the Behavioral Risk Factor Surveillance System (BRFSS) for the general population at the national, regional, and state levels by age groups. • Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/index.html
Schema: dwv_vacc_data
Table Name: vaccination_coverage_adults_18plus__aetd_68ew
Dataset ID: aetd-68ew
Category: Vaccinations
Tags: immunization, pneumococcal, shingles, td, tdap
Vaccination Coverage and Exemptions among Kindergartners
Description: Vaccination Coverage and Exemptions among Kindergartners • Data on school vaccination coverage and exemptions from the School Vaccination Assessment Program for kindergartners at the national and state levels. • Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/index.html
Schema: dwv_vacc_data
Table Name: vaccination_coverage_exemptions_kinderg__ijqb_a7ye
Dataset ID: ijqb-a7ye
Category: Vaccinations
Tags: any exemption, dt, dtap, dtp, hepatitis b
Vaccination Coverage among Health Care Personnel
Description: Vaccination Coverage among Health Care Personnel • Data on influenza vaccination performance measurement from the National Healthcare Safety Network (NHSN) for hospital-based health care personnel (HCP) at the national and state levels by personnel group. • Additional information available at https://www.cdc.gov/flu/fluvaxview/index.htm
Schema: dwv_vacc_data
Table Name: vaccination_coverage_hcp__xerk_pcm8
Dataset ID: xerk-pcm8
Category: Vaccinations
Tags: flu vaccination, immunization, influenza, vaccination, vaccination coverage
Vaccination Coverage among Nursing Home Residents
Description: Vaccination Coverage among Nursing Home Residents • Data on influenza and pneumococcal vaccination coverage from the Long-Term Care Minimum Data Set (MDS) from the Centers for Medicare & Medicaid Services (CMS) at the national, regional, and state levels by sociodemographic characteristics. • Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/index.html and https://www.cdc.gov/flu/fluvaxview/index.htm
Schema: dwv_vacc_data
Table Name: vaccination_coverage_nursing_home_resid__8w4j_reb4
Dataset ID: 8w4j-reb4
Category: Vaccinations
Tags: immunization, influenza, nursing home vaccination, pneumococcal, vaccination
Vaccines.gov: COVID-19 vaccinating provider locations
Description: Because inventory reporting is no longer required, Vaccines.gov information will not be updated on this site after July 2024.
Schema: dwv_vacc_data
Table Name: vaccines_gov_covid_vaccine_locations__5jp2_pgaw
Dataset ID: 5jp2-pgaw
Category: Vaccinations
Tags: covid-19, providers, vaccination locations, vaccination sites, vaccinefinder
Vaccine Hesitancy for COVID-19: County and local estimates
Description: Due to the change in the survey instrument regarding intention to vaccinate, our estimates for “hesitant or unsure” or “hesitant” derived from April 14-26, 2021, are not directly comparable with prior Household Pulse Survey data and should not be used to examine trends in hesitancy. To support state and local communication and outreach efforts, ASPE developed state, county, and sub-state level predictions of hesitancy rates (https://aspe.hhs.gov/pdf-report/vaccine-hesitancy) using the most recently available federal survey data. We estimate hesitancy rates at the state level using the U.S. Census Bureau’s Household Pulse Survey (HPS) (https://www.census.gov/programs-surveys/household-pulse-survey.html) data and utilize the estimated values to predict hesitancy rates at the Public Use Microdata Areas (PUMA) level using the Census Bureau’s 2019 American Community Survey (ACS) 1-year Public Use Microdata Sample (PUMS)(https://www.census.gov/programs-surveys/acs/microdata.html). To create county-level estimates, we used a PUMA-to-county crosswalk from the Missouri Census Data Center(https://mcdc.missouri.edu/applications/geocorr2014.html). PUMAs spanning multiple counties had their estimates apportioned across those counties based on overall 2010 Census populations. The HPS is nationally representative and includes information on U.S. residents’ intentions to receive the COVID-19 vaccine when available, as well as other sociodemographic and geographic (state, region and metropolitan statistical areas) information. The ACS is a nationally representative survey, and it provides key sociodemographic and geographic (state, region, PUMAs, county) information. We utilized data for the survey collection period May 26, 2021 – June 7, 2021, which the HPS refers to as Week 31.. PUMA COVID-19 Hesitancy Data - https://data.cdc.gov/Vaccinations/Vaccine-Hesitancy-for-COVID-19-Public-Use-Microdat/djj9-kh3p
Schema: dwv_vacc_data
Table Name: vaccine_hesitancy_covid19_county_local___q9mh_h2tw
Dataset ID: q9mh-h2tw
Category: Vaccinations
Tags: coronavirus, covid-19, vaccine hesitancy
Vaccine Hesitancy for COVID-19: Public Use Microdata Areas (PUMAs)
Description: Due to the change in the survey instrument regarding intention to vaccinate, our estimates for “hesitant or unsure” or “hesitant” derived from April 14-26, 2021, are not directly comparable with prior Household Pulse Survey data and should not be used to examine trends in hesitancy. To support state and local communication and outreach efforts, ASPE developed state, county, and sub-state level predictions of hesitancy rates(https://aspe.hhs.gov/pdf-report/vaccine-hesitancy) using the most recently available federal survey data. We estimate hesitancy rates at the state level using the U.S. Census Bureau’s Household Pulse Survey (HPS)(https://www.census.gov/programs-surveys/household-pulse-survey.html) data and utilize the estimated values to predict hesitancy rates in more granular areas using the Census Bureau’s 2019 American Community Survey (ACS) 1-year Public Use Microdata Sample (PUMS)(https://www.census.gov/programs-surveys/acs/microdata.html). Public Use Microdata Areas (PUMA) level – PUMAs are geographic areas within each state that contain no fewer than 100,000 people. PUMAs can consist of part of a single densely populated county or can combine parts or all of multiple counties that are less densely populated. The HPS is nationally representative and includes information on U.S. residents’ intentions to receive the COVID-19 vaccine when available, as well as other sociodemographic and geographic (state, region and metropolitan statistical areas) information. The ACS is a nationally representative survey, and it provides key sociodemographic and geographic (state, region, PUMAs, county) information. We utilized data for the survey collection period May 26, 2021 – June 7, 2021, which the HPS refers to as Week 31. County and State Hesitancy Data - https://data.cdc.gov/Vaccinations/Vaccine-Hesitancy-for-COVID-19-County-and-local-es/q9mh-h2tw
Schema: dwv_vacc_data
Table Name: vaccine_hesitancy_covid19_pumas_his_ide__djj9_kh3p
Dataset ID: djj9-kh3p
Category: Vaccinations
Tags: coronavirus, covid-19, vaccine hesitancy
Archived Cumulative Data: Percent of pregnant people aged 18-49 years receiving at least one dose of a COVID-19 vaccine during pregnancy overall, by race/ethnicity, and date reported to CDC-Vaccine Safety Datalink*, United States | December 20, 2020 – Jan
Description: These archived cumulative COVID-19 vaccination coverage estimates are for persons who were pregnant anytime from December 20, 2020, to January 20, 2022, and received at least 1 dose of COVID-19 vaccine during pregnancy based on data from the Vaccine Safety Datalink*. As of January 20, 2022, after moving to reporting weekly estimates, the figures on https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women no longer present cumulative estimates, and these archived data are no longer updated. For these cumulative data, on December 15, 2021, an error was identified where pregnant people who had received an additional or booster dose of a COVID-19 vaccine were not included in the coverage estimates. After correcting the error, coverage estimates for the week of December 11, 2021, increased overall and by race/ethnicity. The persons that were inadvertently excluded have been counted in the December 11, 2021, estimates. Prior weeks’ estimates have not been updated.
Schema: dwv_vacc_data
Table Name: vaccine_preg_covid19_race_ethnicity_dat__4ht3_nbmd
Dataset ID: 4ht3-nbmd
Category: Vaccinations
Tags: covid-19 vaccine, covid tracker, pregnancy, vsd
Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Season and Age Group, United States
Description: - Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Pharmacies and Physical Medical Offices, Adults 18 Years and Older, United States - Estimated number of COVID-19 vaccinations among adults 18 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, stores, and independent pharmacies) and physician medical offices.
Schema: dwv_vacc_data
Table Name: weekly_covid19_vaccinations_pharmacies___ewpg_rz7g
Dataset ID: ewpg-rz7g
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, vsd
Source Data: https://data.cdc.gov/d/ewpg-rz7g
Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024–25 and 2023–24 Among Adults 18 Years, Overall, by Selected Demographics
Description: • Weekly COVID-19 Vaccination Coverage and Comparison among adults 18 Years and Older by Jurisdiction • Weekly estimates of COVID-19 vaccination coverage and intent for vaccination among adults are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/index.html). • Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 COVID-19 vaccines were first available at the end of August 2024.
Schema: dwv_vacc_data
Table Name: weekly_covid19_vaccination_coverage_dif__8yup_c35n
Dataset ID: 8yup-c35n
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, nis-flu, vsd
Source Data: https://data.cdc.gov/d/8yup-c35n
Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024–25 and 2023–24, Overall, by Jurisdiction Among Adults 18 Years
Description: Weekly COVID-19 Vaccination Coverage of Adults18 Years and Older by Jurisdiction • Weekly estimates of COVID-19 vaccination coverage and intent among adults 18 years and older are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM)(https://www.cdc.gov/nis/about/index.html). Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 COVID-19 vaccines were first available at the end of August 2024.
Schema: dwv_vacc_data
Table Name: weekly_covid19_vaccination_coverage_dif__eanj_9nie
Dataset ID: eanj-9nie
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, nis-flu, vsd
Source Data: https://data.cdc.gov/d/eanj-9nie
Weekly Cumulative COVID-19 Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older
Description: Weekly COVID-19 Vaccination Coverage and intent among adults 18 Years and Older by Demographic Characteristics and Jurisdiction • Weekly estimates of COVID-19 vaccination coverage and intent among adults 18 years and older are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/). Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 COVID-19 vaccines were first available at the end of August 2024.
Schema: dwv_vacc_data
Table Name: weekly_covid19_vaccination_coverage_int__ksfb_ug5d
Dataset ID: ksfb-ug5d
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis-acm, nis-flu, vsd
Source Data: https://data.cdc.gov/d/ksfb-ug5d
Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims
Description: Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physical Medical Offices, Adults 18 Years and Older, United States • Estimated number of updated COVID-19 vaccinations among adults 18 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. • Starting in September 2023, the CDC recommended the updated 2023-2024 COVID-19 vaccine for adults ages 18 years and older.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_covid19_vaccinations___w76m_r924
Dataset ID: w76m-r924
Category: Vaccinations
Tags: adults, covid-19 vaccination, iqvia
Weekly Cumulative Updated 2023-24 COVID-19 Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse
Description: Weekly Cumulative Updated 2023-24 COVID-19 Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years • Estimated COVID-19 vaccination coverage among Medicare fee-for-service beneficiaries >65 years is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS). • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine to protect against serious illness from COVID-19. (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html)
Schema: dwv_vacc_data
Table Name: weekly_cumulative_covid19_vaccination_c__brsb_akdp
Dataset ID: brsb-akdp
Category: Vaccinations
Tags: adults, covid-19 vaccination
Weekly Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine by Jurisdiction
Description: Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Jurisdiction • COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_covid19_vaccination_p__sjpm_fk4b
Dataset ID: sjpm-fk4b
Category: Vaccinations
Tags: adults, covid-19 vaccination, nis-acm
Weekly Cumulative COVID-19 Vaccination Coverage, by Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years
Description: • Weekly Cumulative COVID-19 Vaccination Coverage, by Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries, Adults aged 65 years and Older • COVID-19 vaccination coverage among Medicare fee-for-service beneficiaries aged 65 years and older is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS).
Schema: dwv_vacc_data
Table Name: weekly_cumulative_covid_vaccinations_se__jjpx_mxt8
Dataset ID: jjpx-mxt8
Category: Vaccinations
Tags: covid-19 vaccination, iis, iqvia, nis, vsd
Source Data: https://data.cdc.gov/d/jjpx-mxt8
Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States
Description: Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States • Archived data are available here: https://data.cdc.gov/resource/e5zk-7tx5 • Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers have projected that they will supply the United States with as many as 173.5 million to 183.5 million doses of influenza vaccines for the 2022-2023 season. • Additional information is available: https://www.cdc.gov/flu/prevent/vaccine-supply-distribution.htm.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_doses_influenza_vacci__k87d_gv3u
Dataset ID: k87d-gv3u
Category: Vaccinations
Tags: flu, flu vaccination, influenza
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States
Description: Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States - Archived data are here: https://data.cdc.gov/resource/uxgd-cqqc - CDC is exploring use of data obtained from IQVIA§ (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. - These projected pharmacy estimates include flu vaccinations that were billed for (i.e. claims) or paid by cash. Medical office projected estimates are claims-based only. - The sampled pharmacies and physician medical offices and the captured volume of transactions represent approximately 92% and 82% of influenza vaccines administered nationally, respectively. - Vaccinations administered in other settings such as workplaces and community settings are not included in these data. *National estimates for pharmacies and medical offices include vaccinations administered in 50 states and DC. National estimates for medical office vaccinations do not include doses where geographic information (i.e. which state the dose was administered in) was missing. Pharmacy data are through Friday of each week and medical office data are through Saturday of each week. Week ending dates for prior seasons are aligned with the current season’s week ending dates. § 1) King, L. M., Bartoces, M., Fleming-Dutra, K. E., et. al, L. A. (2020). Changes in US outpatient antibiotic prescriptions from 2011–2016external icon. Clinical Infectious Diseases, 70(3), 370-377. 2) McLaughlin, J. M., Swerdlow, D. L., Khan, F., et. Al (2019). Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United Statesexternal icon. Human vaccines & immunotherapeutics, 15(4), 841-849.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__83ng_twza
Dataset ID: 83ng-twza
Category: Vaccinations
Tags: flu, influenza, iqvia, pharmacy vaccinations, physician medical office vaccinations
Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States
Description: Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States • Archived data are available here: https://data.cdc.gov/resource/vfj2-bfuw • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Final estimates for prior seasons and other flu vaccination data are available at CDC’s FluVaxView: https://www.cdc.gov/flu/fluvaxview/index.htm.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__eudc_n39h
Dataset ID: eudc-n39h
Category: Vaccinations
Tags: children, flu, flu shot, influenza, nis
Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States
Description: Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States • Influenza vaccination coverage among Medicare fee-for-service beneficiaries aged ≥65 years is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS). • Weekly influenza vaccination coverage estimates were calculated using Kaplan-Meier survival analysis, based on beneficiaries enrolled as of August 1, 2019 and followed through May 31, 2020 for 2019-20 flu season; and enrolled as of August 1, 2020 and followed through May 31, 2021 for 2020-21 flu season; and enrolled as of Aug 1, 2021 and followed through May 28, 2022 for the 2021-22 flu season. • Additional information about data source is available https://www2.ccwdata.org/web/guest/home/.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__g57i_yx3r
Dataset ID: g57i-yx3r
Category: Vaccinations
Tags: flu, flu vaccination, influenza
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States (ARCHIVED)
Description: Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States - Since 2019, CDC has been exploring use of data obtained from (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. These data are being presented publicly for the first time this season; further evaluations of these data are underway. - The pharmacy data include flu vaccinations that were billed for (i.e. claims) or paid by cash. Medical office data are claims based. - The sampled pharmacies and physician medical offices and the captured volume of transactions represent approximately 92% and 82% of influenza vaccines administered nationally, respectively. - Vaccinations administered in other settings such as workplaces and community settings are not included in these data. - Weekly Number of Influenza Vaccinations Administered, in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s): IQVIA Pharmacy and Physician Medical Office Claims.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__uxgd_cqqc
Dataset ID: uxgd-cqqc
Category: Vaccinations
Tags: flu, influenza, iqvia, pharmacy vaccinations, physician medical office vaccinations
Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States
Description: Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States • Influenza vaccination coverage among children is assessed through the National Immunization Survey-Flu (NIS-Flu) annually, providing weekly influenza vaccination coverage estimates for children 6 months–17 years based upon parental report. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) o NIS-Flu is a national random-digit-dialed cellular telephone survey of households conducted during the flu season (October-June). • Additional information about NIS-Flu methods and estimates from the 2019-2020 season are available at: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__vfj2_bfuw
Dataset ID: vfj2-bfuw
Category: Vaccinations
Tags: chlidren, flu, flu shot, influenza, nis
Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Flu Season and Age Group, United States
Description: Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physical Medical Offices, Adults 18 Years and Older, United States Archived data are here: https://data.cdc.gov/resource/uxgd-cqqc - Estimated number of influenza vaccinations among adults 18 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, stores, and independent pharmacies) and physician medical offices.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccination__ysd3_txwj
Dataset ID: ysd3-txwj
Category: Vaccinations
Tags: flu vaccination, iis, iqvia, nis-acm, nis-flu, vsd
Source Data: https://data.cdc.gov/d/ysd3-txwj
Weekly Cumulative Influenza Vaccine Doses Distributed in the United States
Description: Weekly Cumulative Influenza Vaccine Doses Distributed in the United States, 2016-2021 • Flu vaccine is produced by private manufacturers. For the 2020-2021 season, manufacturers have projected they will provide as many as 194 to 198 million doses of influenza vaccine for the U.S. market. • Additional information is available: https://www.cdc.gov/flu/prevent/vaccine-supply-distribution.htm.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_influenza_vaccine_dos__e5zk_7tx5
Dataset ID: e5zk-7tx5
Category: Vaccinations
Tags: flu, flu vaccination, influenza
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States
Description: Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 Years and Older, United States • Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices. • Starting in September 2023, the CDC recommended the RSV vaccine for adults 60 years and older.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vaccinations_phar__a3gi_4phs
Dataset ID: a3gi-4phs
Category: Vaccinations
Tags: adults, iqvia, rsv vaccination
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 60 to 74 Years and 75 years and older, United States
Description: •Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 60 to 74 Years and 75 Years and Older, United States • Estimated Number of RSV vaccinations among adults 60 years and older is assessed through IQVIA (https://www.iqvia.com/) as a source of information on vaccinations administered in retail pharmacies (include chain, mass merchandise, food stores, and independent pharmacies) and physician medical offices.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vaccinations_reta__hea5_6w9c
Dataset ID: hea5-6w9c
Category: Vaccinations
Tags: iis, iqvia, nis-acm, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/hea5-6w9c
Weekly Cumulative Percentage of Adults 60 Years and Older Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine by Jurisdiction
Description: Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Jurisdiction • RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vaccination_by_ju__qve4_fp9c
Dataset ID: qve4-fp9c
Category: Vaccinations
Tags: nis-acm, older adults, rsv, vaccination
Differences in Weekly Cumulative Percentage of Adults 60 Years and Older Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine by Selected Demographics
Description: Weekly RSV Vaccination Coverage of Adults 60 Years and Older by Jurisdiction • RSV vaccination coverage among adults 60 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • The CDC recommended the RSV vaccine for adults 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vaccine_demograph__5vw4_awn6
Dataset ID: 5vw4-awn6
Category: Vaccinations
Tags: nis-acm, older adults, rsv, vaccination
Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States
Description: • Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60─74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction • Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60─74 years with high risk conditions are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/index.html). • In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vacc_coverage_dem__k4cb_dxd7
Dataset ID: k4cb-dxd7
Category: Vaccinations
Tags: iis, iqvia, nis-acm, nis-flu, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/k4cb-dxd7
Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse
Description: Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged 65 years • Estimated COVID-19 vaccination coverage among Medicare fee-for-service beneficiaries >65 years is assessed using data files from the Medicare Fee-For-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS). • Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vacc_coverage_rac__55uq_699y
Dataset ID: 55uq-699y
Category: Vaccinations
Tags: older adults, rsv, vaccination
Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥75 years and enrolled in a Part D plan, United States, Data Source: Centers for Medicare & Medicaid Services Chronic Conditions Warehouse
Description: • Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged 75 years • RSV vaccination coverage among Medicare-Fee-for-service beneficiaries aged 75 years and older and enrolled in a Part D plan in assessed using data files from the Medicare Fee-for-Service (FFS) administrative claims data managed by the Centers for Medicare & Medicaid Services (CMS).
Schema: dwv_vacc_data
Table Name: weekly_cumulative_rsv_vacc_coverage_rac__nqu5_vn7d
Dataset ID: nqu5-vn7d
Category: Vaccinations
Tags: iis, iqvia, nis, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/nqu5-vn7d
Weekly Differences in Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine by Selected Demographics
Description: Weekly COVID-19 Vaccination Coverage of Adults 18 Years and Older by Jurisdiction • COVID-19 vaccination coverage among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module, providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.
Schema: dwv_vacc_data
Table Name: weekly_diff_cumulative_percent_vaccinat__kevv_m5vs
Dataset ID: kevv-m5vs
Category: Vaccinations
Tags: adults, covid-19 vaccination, nis-acm
Weekly Intent for Vaccination and Cumulative Percentage of Adults 18 Years and Older Vaccinated with Updated 2023-24 COVID-19 Vaccine
Description: • COVID-19 vaccination coverage and intent among adults 18 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly COVID-19 vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • Starting in September 2023, the CDC recommended the 2023-2024 updated COVID-19 vaccine for adults ages 18 years and older.
Schema: dwv_vacc_data
Table Name: weekly_intent_vaccination_cumulative_ad__pakc_hru3
Dataset ID: pakc-hru3
Category: Vaccinations
Tags: adults, covid-19 vaccination, nis-acm
Weekly Intent for Vaccination and Cumulative Percentage of Adults 60 Years and Older Vaccinated with RSV Vaccine
Description: Weekly Intent for Vaccination and Cumulative Percentage of Adults 60 Years and Older Vaccinated with RSV Vaccine. • RSV vaccination coverage among adults ages 60 years and older is assessed through the National Immunization Survey-Adult COVID Module providing weekly RSV vaccination coverage estimates. (https://www.cdc.gov/vaccines/imz-managers/nis/about.html) • The CDC recommended the RSV vaccine for adults ages 60 years and older in July 2023. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Schema: dwv_vacc_data
Table Name: weekly_intent_vaccination_cumulative_pe__gzbv_dn9g
Dataset ID: gzbv-dn9g
Category: Vaccinations
Tags: nis-acm, older adults, rsv, vaccination
Weekly Respiratory Virus Vaccination Data, Children 6 Months-17 Years and Adults 18 Years and Older, National Immunization Survey
Description: *Vaccination data updates for the 2024-2025 respiratory illness season ended on May 2, 2025. The weekly respiratory virus vaccination data come from the National Immunization Survey-Adult COVID Module (NIS-ACM), National Immunization Survey-Child COVID Module (NIS-CCM), and the National Immunization Survey-Flu (NIS-Flu). The NIS-ACM provides data on Influenza (flu), COVID-19, and RSV vaccination for adults aged ≥18 years in the United States. The NIS-CCM provides data on COVID-19 vaccination for children aged 6 months-17 years in the United States. The NIS-Flu provides data on Influenza vaccination for children aged 6 months-17 years in the United States National Immunization Survey data are collected by telephone interview using a random-digit-dialed sample of cellular telephone numbers stratified by state, the District of Columbia, five local jurisdictions (Bexar County TX, Chicago IL, Houston TX, New York City NY, and Philadelphia County PA), and Guam, Puerto Rico, and the United States Virgin Islands. Data are weighted to represent the non-institutionalized United States population and mitigate possible bias that can result from incomplete sample frame (exclusion of households with no phone service or only landline telephones) or non-response. All responses are self-reported, or reported by a parent for children 6 months-17 years. For more information about the surveys, see https://www.cdc.gov/vaccines/imz-managers/nis/about.html#current-surveys. Estimates should be interpreted with caution when there is a small sample size or wide confidence interval.
Schema: dwv_vacc_data
Table Name: weekly_respiratory_virus_vaccination_da__5c6r_xi2t
Dataset ID: 5c6r-xi2t
Category: Vaccinations
Tags: coronavirus, covid19, immunization, ncird, nis-acm, nis-ccm, respiratory-virus-response, rsv, vaccination, vaccination-coverage
Source Data: https://data.cdc.gov/d/5c6r-xi2t
Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60–74 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics
Description: • Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60─74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction • Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60─74 years with high risk conditions are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/) • In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.
Schema: dwv_vacc_data
Table Name: weekly_rsv_vaccination_coverage_differe__ndai_i7s4
Dataset ID: ndai-i7s4
Category: Vaccinations
Tags: iis, iqvia, nis-acm, nis-flu, rsv vaccination, vsd
Source Data: https://data.cdc.gov/d/ndai-i7s4
Last updated